Belen Garijo, the CEO of the Merck Group is still making sure that the company is committed to science, healthcare and innovation. This is happening at a time when the world economy’s very uncertain and it is changing the way life sciences and technology work. Belen Garijo is leading the Merck Group to be strong and focused on research. The Merck Group wants to keep growing in a way that’s good for the planet and find new innovative solutions that will help people all around the world. The Merck Group is working hard to make a difference, in global health. Belen Garijo and the Merck Group are doing this by being committed to science, healthcare and innovation.
Garijo, who became the CEO in 2021 always says that decisions should be based on science. Now it is 2026. This way of doing things is really important. Lots of companies that make medicines do life science work. Make electronics are having a tough time. They have to deal with costs going up rules changing and new technology coming out fast. Merck has a lot of things they do. They are in Healthcare, Life Science and Electronics. This helps Merck balance when the market is not doing well now with the big plans they have, for the future. Merck is doing this by having a mix of Healthcare, Life Science and Electronics which’s their main business areas.
Mercks healthcare business is very important to Garijo. He wants to make it stronger. The company is working hard on things, like cancer, brain problems and helping people have babies. They are spending a lot of money to find ways to help people. Merck wants to make treatments that people really need. They are trying to make treatments that do not just help people live longer. Also make their lives better. Merck is focusing on what patients need and want. They want to make peoples lives all around the world. Mercks healthcare business is a part of this.
In the Life Science division Garijo has made Merck an important partner to companies that make new medicines, schools and other places that make drugs. The things Merck makes like tools for labs and ways to make medicines help people find new drugs make vaccines and do new kinds of treatments like using cells and genes to fix problems. Because people around the world want new medicines to be made faster and better what Merck does in Life Science is very important to everyone who cares about health. Mercks Life Science work is really crucial, to the system of taking care of peoples health.
Merck is a company that Garijo’s really focused on especially when it comes to the Electronics business. The Electronics business at Merck is very important for the semiconductor and display industries.
Merck is doing a lot of work with digitalization and intelligence and electric mobility. These things are making people want advanced materials.
So Merck is putting money into technologies that will help make high-performance chips and also make electronics in a way that is good for the earth.
The Electronics business, at Merck is a part of what Garijo wants for the company. He wants Merck to be a science company that helps people make progress in areas, not just medicine.
Garijo is a person who really cares about things beyond how well the company is doing. She thinks it is very important to take care of the earth and make sure everyone is treated fairly. Garijo says that if a company wants to be successful for a time it needs to make money and also be kind, to the environment and people.
At Merck they are doing things to help the earth and make sure they are buying things from people who are treated fairly. These things are a part of what the company is trying to do not just something they are doing on the side.
Garijo is a leader who’s really calm and likes to think things through. She has a background in medicine. Has worked with people from many different countries, which helps her understand what is going on around the world. This is very helpful for Merck because Garijo can make decisions for the company. Garijos way of leading has helped Merck stay steady and keep coming up with ideas even when things get really tough and confusing. Garijos leadership style is good, for Merck.
As 2026 unfolds, Belen Garijo’s focus on science, healthcare innovation, and sustainable growth continues to shape Merck Group’s trajectory. By doubling down on research excellence and long-term value creation, she is steering the 350-year-old German company toward a future where scientific progress and societal benefit remain at the core of its mission.
